Arlington Trust’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $957K | Buy |
12,230
+1,138
| +10% | +$89K | 0.19% | 68 |
|
|
2025
Q1 | $804K | Buy |
11,092
+135
| +1% | +$9.79K | 0.17% | 74 |
|
|
2024
Q4 | $811K | Buy |
10,957
+120
| +1% | +$8.88K | 0.17% | 71 |
|
|
2024
Q3 | $715K | Sell |
10,837
-613
| -5% | -$40.5K | 0.16% | 78 |
|
|
2024
Q2 | $1.06M | Sell |
11,450
-832
| -7% | -$76.9K | 0.25% | 55 |
|
|
2024
Q1 | $1.17M | Sell |
12,282
-24
| -0.2% | -$2.29K | 0.3% | 50 |
|
|
2023
Q4 | $938K | Buy |
12,306
+12,069
| +5,092% | +$920K | 0.26% | 57 |
|
|
2023
Q3 | $16.4K | Buy |
+237
| New | +$16.4K | 0.01% | 198 |
|